Technical Analysis for SCNLF - Scancell Holdings Plc Ord

Grade Last Price % Change Price Change
grade F 0.08 -33.33% -0.0400
SCNLF closed down 33.33 percent on Friday, September 27, 2019, on 2.51 times normal volume. The bears made the stock sink to a new 52-week low.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical SCNLF trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Gapped Down Weakness 0.00%
New 52 Week Closing Low Bearish -33.33%
Narrow Range Bar Range Contraction -33.33%
New 52 Week Low Weakness -33.33%
Gapped Down Weakness -33.33%
Narrow Range Bar Range Contraction -42.86%

Older signals for SCNLF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Scancell Holdings plc, a biopharmaceutical company, engages in the discovery and development of novel monoclonal antibodies and vaccines for the treatment of cancer based on its ImmunoBody and Moditope platforms in the United Kingdom. Its products include SCIB1, a plasmid DNA vaccine, which is in Phase I/II clinical trials for the treatment of melanoma; SCIB2 to treat lung cancer antigen; and Modi-1, which is in the pre-clinical development to treat triple negative breast cancer, ovarian cancer, and sarcoma. Scancell Holdings plc has a research collaboration agreement with BioNTech to develop T-cell therapies for the treatment of cancer. It also has a licensing and collaboration agreement with ISA Pharmaceuticals B.V. to use ISA's AMPLIVANT adjuvant technology for the manufacturing, development, and commercialization of Modi-1. The company was incorporated in 2008 and is based in Oxford, the United Kingdom.
Medicine Health Manufacturing Biotechnology RTT Cancer Biopharmaceutical Treatment Of Cancer Antibodies Vaccination Melanoma Ovarian Cancer Vaccine Lung Cancer Cancer Vaccines Triple Negative Breast Cancer Experimental Cancer Treatments Treatment Of Melanoma
Is SCNLF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 0.245
52 Week Low 0.08
Average Volume 4,780
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.1624
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0800
Resistance 3 (R3) 0.0800 0.0800 0.0800
Resistance 2 (R2) 0.0800 0.0800 0.0800 0.0800
Resistance 1 (R1) 0.0800 0.0800 0.0800 0.0800 0.0800
Pivot Point 0.0800 0.0800 0.0800 0.0800 0.0800
Support 1 (S1) 0.0800 0.0800 0.0800 0.0800 0.0800
Support 2 (S2) 0.0800 0.0800 0.0800 0.0800
Support 3 (S3) 0.0800 0.0800 0.0800
Support 4 (S4) 0.0800